View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | Israel |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2031-06-01 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1000.00 |
| Coupon | 4.125 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1000.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Teva Pharmaceutical Finance Netherlands II B.V. corporate note has a 4.13% fixed rate coupon paid on a annual basis. It was issued on May 28, 2025 with an issue size of 1000.00 million EUR and matures on June 01, 2031 with a last coupon date of June 01, 2030. |
Teva Pharmaceutical Finance Netherlands II B.V., established in the Netherlands, serves as a finance subsidiary of Teva Pharmaceutical Industries Ltd., headquartered in Israel. The company primarily focuses on raising funds through the issuance of bonds to support the broader financing needs of its parent organization and facilitate operational growth.